Teva launches generic version of Celebrex caps

JERUSALEM — Teva Pharmaceutical Industries on Wednesday announced the launch of generic Celebrex (celecoxib) capsules in the United States. The company is offering the capsules in 50-,100-, 200- and 400-mg dosage strengths. 

 

“Teva is pleased to be the first to launch generic Celebrex. The addition of Celecoxib Capsules to our U.S. generics portfolio is further evidence of Teva’s commitment to bring affordable treatment solutions to patients,” said Siggi Olafsson, president and CEO of global generic medicines at Teva.

 

Celebrex, marketed by Pfizer, had annual sales of $2.56 billion in the United States as of Oct. 2014, according to IMS data.